Morphological changes in the area of implanting "Parietene ProGrip" endoprosthesis as a result of using Solcoseryl
Using the proper type of endoprosthesis which is combined with medicines reducing inflammation in the implantation area could decrease relapses as well as improve quality of treatment. We used endoprosthesis «Parietene ProGrip» when working with laboratory animals. The animals of the experimental group were given the solution of Solcoseryl every other day within 90 days, at first intraoperatively, then intraperitoneally. The animals from the control group didn't get the drug. The combination of «Parietene ProGrip» endoprosthesis together with Solcoseryl created special conditions for reducing inflammation area, increasing pool of fibroblasts. A capsule made from compact fibrous connective tissue formed a solid carcass whose main function was mechanical: keeping together filaments of endoprosthesis. It will set a lasting link with surrounded tissues and improve management results at the end.